BioCentury
ARTICLE | Company News

Alopexx Enterprises LLC, Provenance deal

January 2, 2012 8:00 AM UTC

Alopexx and Provenance formed a JV to develop and commercialize Provenance's DI-Leu16-IL2. Provenance will contribute the compound and Alopexx will contribute $8 million to the JV, which will be name...